Closing in on a new treatment for sleeping sickness.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 23853715.
- Also identified by DOI 10.7554/eLife.01042 and PMC identifier 3707054.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
A chemoproteomics approach has been employed to identify a kinase that could be used as a druggable target in efforts to develop new treatments for African sleeping sickness.
Medical subject headings
- Antiprotozoal Agents
- Fungi
- Trypanosoma brucei brucei
- Zearalenone